Potential interaction between clorsulon and ivermectin for malaria vector control.
Hongsuwong T. et al, (2025), Med Vet Entomol, 39, 393 - 397
Dose-Optimization of a Novel Co-Formulated Triple Combination Antimalarial Therapy: Artemether-Lumefantrine-Amodiaquine.
Tarning J. et al, (2025), Clin Pharmacol Ther, 117, 1248 - 1253
Pharmacokinetic-pharmacodynamic modeling of benznidazole and its antitrypanosomal activity in a murine model of chronic Chagas disease.
Assmus F. et al, (2025), PLoS Negl Trop Dis, 19
Simplifying medicine dosing for children by harmonising weight bands across therapeutic areas.
Waalewijn H. et al, (2025), Lancet Child Adolesc Health, 9, 274 - 282
Author Correction: Impact of standard and long-lasting ivermectin formulations in cattle and buffalo on wild Anopheles survival on Sumba Island, Indonesia.
Kobylinski KC. et al, (2025), Sci Rep, 15
Potential of emodepside for vector-borne disease control.
Khemrattrakool P. et al, (2025), Malar J, 24
A LC-MS/MS Assay for Quantification of Amodiaquine and Desethylamodiaquine in Dried Blood Spots on Filter Paper.
Kaewkhao N. et al, (2025), Int J Anal Chem, 2025
Inhibition of Giardia duodenalis by isocryptolepine -triazole adducts and derivatives.
Popruk S. et al, (2024), Int J Parasitol Drugs Drug Resist, 26
Impact of standard and long-lasting ivermectin formulations in cattle and buffalo on wild Anopheles survival on Sumba Island, Indonesia.
Kobylinski KC. et al, (2024), Sci Rep, 14
Therapeutics for Nipah virus disease: a systematic review to support prioritisation of drug candidates for clinical trials.
Chan XHS. et al, (2024), Lancet Microbe
Pharmacometric and statistical considerations for dose optimization.
Chotsiri P. et al, (2024), CPT Pharmacometrics Syst Pharmacol
Primaquine for uncomplicated Plasmodium vivax malaria in children younger than 15 years: a systematic review and individual patient data meta-analysis.
Commons RJ. et al, (2024), Lancet Child Adolesc Health, 8, 798 - 808
Author Correction: Ivermectin metabolites reduce Anopheles survival.
Kobylinski KC. et al, (2024), Sci Rep, 14
Safety and pharmacokinetic properties of a new formulation of parenteral artesunate in healthy Thai volunteers.
Tarning J. et al, (2024), Malar J, 23
Addressing health equity for breastfeeding women: primaquine for Plasmodium vivax radical cure.
Abla N. et al, (2024), Malar J, 23
In-host modeling of dengue virus and non-structural protein 1 and the effects of ivermectin in patients with acute dengue fever.
Ding J. et al, (2024), CPT Pharmacometrics Syst Pharmacol
Population pharmacokinetics of amodiaquine and piperaquine in African pregnant women with uncomplicated Plasmodium falciparum infections.
Ding J. et al, (2024), CPT Pharmacometrics Syst Pharmacol
Evaluation of hydroxychloroquine or chloroquine for the prevention of COVID-19 (COPCOV): A double-blind, randomised, placebo-controlled trial.
Schilling WHK. et al, (2024), PLoS Med, 21
Temporal changes in SARS-CoV-2 clearance kinetics and the optimal design of antiviral pharmacodynamic studies: an individual patient data meta-analysis of a randomised, controlled, adaptive platform study (PLATCOV).
Wongnak P. et al, (2024), Lancet Infect Dis, 24, 953 - 963